Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.
The precision medicine company recently announced a pair of strategic alliances aimed at expanding access to new cancer diagnostics.
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.